Breaking

healthcare

User access blocked by platform
Research Drops

User access blocked by platform

Oncologists face insurance delays and logistical hurdles blocking access to advanced cancer treatments like CAR T-cell therapy.

Florinda Ashbridge · August 4, 2026
User access denied after system block
Daily Health

User access denied after system block

Experts discuss barriers to obesity care access and explore policy solutions for ensuring consistent patient treatment options are effectively delivered.

Zenobia Fairweather · August 4, 2026
Users Alarmed After Platform Announces Blocking Policy
Research Drops

Users Alarmed After Platform Announces Blocking Policy

Vitamin D deficiency linked to kidney disease affects bone health, blood pressure, immune function and survival, revealing a critical public health issue.

Zenobia Fairweather · August 3, 2026
Online Service Blocks Users Over Policy Violations
Drug Watch

Online Service Blocks Users Over Policy Violations

Pharmacy oncology is reshaping cancer care as Minnesota leaders tackle operational and financial hurdles to expand outpatient bispecific antibody and CAR T‑cell

Zenobia Fairweather · August 3, 2026
User Blocked After Policy Violation
Daily Health

User Blocked After Policy Violation

The multiple myeloma trial reveals an 89% lower risk of disease progression or death with the teclistamab‑talquetamab combo, offering new hope for…

Florinda Ashbridge · August 2, 2026
Sorry, You Have Been Blocked
Daily Health

Sorry, You Have Been Blocked

Breast cancer care access improves with new geriatric oncology clinics like the University of Colorado Anschutz, coordinating specialists for better patient out

Zenobia Fairweather · July 30, 2026
User Blocked After Violation of Platform Policies
Daily Health

User Blocked After Violation of Platform Policies

Wildfire smoke asthma risk rises as dense plumes degrade air quality across the Pacific Northwest, prompting emergency health guidance for sufferers and…

Florinda Ashbridge · July 30, 2026
User blocked from platform after policy breach
Research Drops

User blocked from platform after policy breach

A new psoriasis pill, zasocitinib, shows 70% skin clearance rates matching injectable biologics in phase 3 trials. Learn how it compares.

Zenobia Fairweather · July 29, 2026
User access restricted after policy breach
Research Drops

User access restricted after policy breach

The FDA approved Simtriyo, a new ADHD medication for adults and children, improving focus and emotional regulation with extended-release benefits.

Florinda Ashbridge · July 28, 2026
User Blocked After Violating Platform Policies
Daily Health

User Blocked After Violating Platform Policies

System alignment is the top hurdle for healthcare leaders, according to the TPG Chief Pharmacy Officer Summit, which found coordination gaps outweigh…

Florinda Ashbridge · July 27, 2026